Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEN
2076
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $16.9M | ﹤0.01% |
1,186,739
+83,120
| +8% | +$1.34M |
|
2077
AngioDynamics
ANGO
$647M
| $16.9M | ﹤0.01% |
652,763
+10,916
| +2% | +$292K |
|
|
ECOL
2078
DELISTED
US Ecology, Inc.
ECOL
| $16.9M | ﹤0.01% |
523,400
-18,345
| -3% | -$659K |
|
2079
Kinross Gold
KGC
$31.9B
| $16.9M | ﹤0.01% |
3,168,302
+291,487
| +10% | +$1.75M |
|
2080
CoreCivic
CXW
$3.13B
| $16.9M | ﹤0.01% |
1,899,522
-73,028
| -4% | -$711K |
|
2081
Central Garden & Pet Co Class A
CENTA
$2.41B
| $16.9M | ﹤0.01% |
490,923
+1,959
| +0.4% | +$67.7K |
|
|
NTST
2082
NETSTREIT Corp
NTST
$2.09B
| $16.8M | ﹤0.01% |
710,183
+56,147
| +9% | +$1.42M |
|
|
VXRT
2083
DELISTED
Vaxart
VXRT
| $16.8M | ﹤0.01% |
2,112,241
+83,238
| +4% | +$685K |
|
2084
Apogee Enterprises
APOG
$888M
| $16.7M | ﹤0.01% |
443,396
+3,116
| +0.7% | +$125K |
|
|
DHC
2085
Diversified Healthcare Trust
DHC
$2.03B
| $16.6M | ﹤0.01% |
4,910,421
-287,518
| -6% | -$1.08M |
|
2086
Krystal Biotech
KRYS
$9.72B
| $16.6M | ﹤0.01% |
317,608
-2,568
| -0.8% | -$152K |
|
|
GOOD
2087
Gladstone Commercial Corp
GOOD
$641M
| $16.6M | ﹤0.01% |
787,547
+7,284
| +0.9% | +$163K |
|
2088
Dillards
DDS
$9.59B
| $16.6M | ﹤0.01% |
95,949
-23,633
| -20% | -$4.5M |
|
|
GDEN
2089
DELISTED
Golden Entertainment
GDEN
| $16.5M | ﹤0.01% |
337,091
+6,122
| +2% | +$285K |
|
2090
Innoviva
INVA
$1.5B
| $16.5M | ﹤0.01% |
989,779
-144,810
| -13% | -$2.17M |
|
2091
BJ's Restaurants
BJRI
$1.42B
| $16.5M | ﹤0.01% |
395,032
+2,805
| +0.7% | +$118K |
|
2092
OrthoPediatrics
KIDS
$653M
| $16.5M | ﹤0.01% |
251,533
+19,151
| +8% | +$1.24M |
|
|
YMAB
2093
DELISTED
Y-mAbs Therapeutics
YMAB
| $16.5M | ﹤0.01% |
577,111
+26,064
| +5% | +$821K |
|
|
ZGNX
2094
DELISTED
Zogenix, Inc.
ZGNX
| $16.5M | ﹤0.01% |
1,083,775
+74,614
| +7% | +$1.17M |
|
2095
CEVA Inc
CEVA
$855M
| $16.4M | ﹤0.01% |
385,372
+1,420
| +0.4% | +$64.4K |
|
2096
Adtran
ADTN
$658M
| $16.4M | ﹤0.01% |
872,652
+6,105
| +0.7% | +$128K |
|
|
KAMN
2097
DELISTED
Kaman Corp
KAMN
| $16.3M | ﹤0.01% |
457,657
-7,791
| -2% | -$322K |
|
|
VRAY
2098
DELISTED
ViewRay, Inc.
VRAY
| $16.3M | ﹤0.01% |
2,261,494
+103,223
| +5% | +$652K |
|
2099
Zumiez
ZUMZ
$319M
| $16.3M | ﹤0.01% |
409,969
+33,425
| +9% | +$1.43M |
|
|
TVTY
2100
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $16.3M | ﹤0.01% |
704,722
+5,497
| +0.8% | +$130K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.